ReNAgade Therapeutics, the company unlocking the limitless potential of RNA medicines, appoints Paul Perrault to its board of directors, effective December 5, 2023. I announced what I had done. Mr. Perrault most recently served as Chief Executive Officer of CSL and has more than 40 years of leadership experience in the biotechnology industry.
Paul is a renowned industry executive with an extensive track record in drug development and has been an integral part of CSL’s growth into an international leader in the field. His leadership and extensive knowledge of the biotechnology industry , will be an invaluable asset as we build our portfolio of novel RNA medicines,” said Amit D. Munshi, Chief Executive Officer of ReNAgade. “We are pleased to welcome Paul to the ReNAgade team and look forward to his contributions.”
“I am delighted to be working with ReNAgade during this exciting time,” said Perrault. “ReNAgade is led by a world-class management team and its innovative technology has the potential to advance the RNA medicine field on an unprecedented scale in the coming years.”
Mr. Perrault has more than 40 years of experience in the global biotechnology and pharmaceutical industries, most recently as CEO and Managing Director of CSL. During his 25-year career at CSL, he oversaw operations in more than 40 countries, including major manufacturing locations in the United States, Switzerland, Germany, and Australia, and an extensive network of plasma collection centers throughout North America and Germany. , Wyeth, Centeon, Aventis Bioservices, and Aventis Behring, and serves on the board of directors of the Research and Pharmaceutical Manufacturers Association of America (PhRMA). In 2019, Mr. Perot was featured on the Harvard Business Review CEO 100 list, recognizing him as one of the world’s highest performing CEOs. He holds a Bachelor of Science in Psychology from the University of Central Florida and completed advanced management training at the Kellogg School of Management and the Wharton School at the University of Pennsylvania.
